In response to topical application of irritants, increased concentrati
ons of prostaglandin E-2 (PGE(2)) are found in human skin exudate and
in cultured dermal fibroblasts. In this study, PGE(2) generated in res
ponse to transdermal delivery of irritant drug compounds was monitored
in hairless guinea pig (HGP) by a non-invasive method, reverse iontop
horesis. Reverse iontophoresis is the movement of molecules from the s
kin under the influence of an applied electric field. Irritant drug co
mpounds were applied with iontophoresis (electrotransport), and revers
e iontophoresis of PGE(2) from skin was monitored by radioimmunoassay
(RIA) after extraction from the delivery system. Chlorpromazine was us
ed as a model drug irritant. When chlorpromazine and saline were appli
ed over a range of current densities from 0 to 200 mu A/cm(2), visual
scores of erythema and edema yielded a correlation with measured skin
efflux of PGE(2) (r = 0.86). Delivery of chlorpromazine resulted in gr
eater efflux of PGE(2) than delivery of non-irritant saline controls u
nder the same delivery conditions, Five drug compounds, chloroquine, p
romazine, chlorpromazine. tetracaine, metoclopramide, and saline were
applied to hairless guinea pig skin. The 6 agents were similarly rank
ordered by visual erythema/edema scores and by PGE(2) efflux, indicati
ng that the quantity of PGE(2) effluxed reflects the intensity of skin
irritation. In contrast, vasoconstriction or vasodilation produced by
the local delivery of vasoactive agents did not correlate with PGE(2)
skin efflux, indicating that this measurement is specific for an infl
ammatory response. In summary, PGE(2) generated in response to transde
rmally applied drug irritants can be monitored non-invasively in vivo
by reverse iontophoresis.